Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Nash

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Pitfalls in the design of clinical trials for prevention or treatment of acute graft-versus-host diseasePaul J Martin, Richard A Nash
Blood|December 25, 2010
Crohn disease: remissions but no cureRichard A Nash, George B McDonald
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2002
High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical reviewHarry Openshaw, Richard A Nash, Peter A McSweeney
The New England Journal of Medicine|September 16, 2006
Cyclophosphamide in scleroderma lung diseaseKeith M Sullivan, Peter A McSweeney, Richard A Nash
Current Rheumatology Reports|March 20, 2009
Is scleroderma a vasculopathy?Jo Nadine Fleming, Richard A Nash, William M Mahoney, et al.
The Journal of Rheumatology|August 13, 2009
Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosisLeona A Holmberg, Daniel E Furst, Peter A McSweeney, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2010
Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic reviewJames T Reston, Stacey Uhl, Jonathan R Treadwell, et al.
Clinical Neurology and Neurosurgery|August 24, 2010
Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical settingAnnette Wundes, George H Kraft, James D Bowen, et al.
Clinical Immunology (Orlando, Fla.)|July 18, 2006
Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosisJan Storek, Richard A Nash, Peter A McSweeney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermatesGeorge E Georges, Marina Lesnikova, Rainer Storb, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Pitfalls in the design of clinical trials for prevention or treatment of acute graft-versus-host diseasePaul J Martin, Richard A Nash
Blood|December 25, 2010
Crohn disease: remissions but no cureRichard A Nash, George B McDonald
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2002
High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical reviewHarry Openshaw, Richard A Nash, Peter A McSweeney
The New England Journal of Medicine|September 16, 2006
Cyclophosphamide in scleroderma lung diseaseKeith M Sullivan, Peter A McSweeney, Richard A Nash
Current Rheumatology Reports|March 20, 2009
Is scleroderma a vasculopathy?Jo Nadine Fleming, Richard A Nash, William M Mahoney, et al.
The Journal of Rheumatology|August 13, 2009
Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosisLeona A Holmberg, Daniel E Furst, Peter A McSweeney, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2010
Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic reviewJames T Reston, Stacey Uhl, Jonathan R Treadwell, et al.
Clinical Neurology and Neurosurgery|August 24, 2010
Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical settingAnnette Wundes, George H Kraft, James D Bowen, et al.
Clinical Immunology (Orlando, Fla.)|July 18, 2006
Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosisJan Storek, Richard A Nash, Peter A McSweeney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermatesGeorge E Georges, Marina Lesnikova, Rainer Storb, et al.
Pageof 8